Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
REGN
REGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
REGN News
Casgevy Therapy Revenue Shows Significant Growth
1d ago
Benzinga
Sanofi Faces Leadership Change Amid Drug Pipeline Challenges
2d ago
Benzinga
Regeneron Unveils 36 Allergy Treatment Abstracts at AAAAI 2026
5d ago
Newsfilter
Regeneron Reports Strong Q4 2024 Earnings with Key Growth Drivers
Feb 05 2026
Yahoo Finance
Regeneron Reports 11% Revenue Growth in Q3 2024 Earnings Call
Feb 05 2026
Yahoo Finance
Cardinal Health Shares Surge Following Earnings Report as CEO Discusses Success Factors.
Feb 05 2026
Barron's
Merck's Stock Outlook Remains Positive Despite Price Repricing
Feb 02 2026
CNBC
Regeneron Reports Strong Q4 Earnings, Beats Expectations
Feb 02 2026
Benzinga
Regeneron Pharmaceuticals Announces 6.8% Dividend Increase
Feb 02 2026
seekingalpha
Regeneron Q4 Results Beat Estimates, Analysts Raise Price Targets
Feb 02 2026
stocktwits
Regeneron Pharmaceuticals Initiates Dividend Payments Amid Steady Growth
Jan 31 2026
Yahoo Finance
McDonald Capital Increases Stake in FactSet Research Systems
Jan 31 2026
Yahoo Finance
Regeneron Pharmaceuticals Reports Q4 2025 Earnings Highlights
Jan 30 2026
seekingalpha
Regeneron Reports Q4 Earnings Beat with Strategic Investments
Jan 30 2026
Benzinga
Regeneron Reports Better-Than-Expected Q4 Earnings Amid Competitive Pressures
Jan 30 2026
stocktwits
Regeneron Reports Q4 2025 Earnings with Strong Performance
Jan 30 2026
seekingalpha
Show More News